HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Perfluorodecalin-enriched fibrin matrix for human islet culture.

Abstract
Disruption of microenvironment and decrease in oxygen supply during isolation and culture lead to pancreatic islet injury and their poor survival after transplantation. This study aimed to create a matrix for culturing islets, using fibrin as scaffold and perfluorodecalin as oxygen diffusion enhancing medium. Human pancreatic islets were divided in four groups: control, islets cultured in fibrin, islets in fibrin containing non-emulsified perfluorodecalin, and finally islets in fibrin supplemented with emulsified perfluorodecalin. After an overnight culture, cell damage (viability, proinsulin and insulin unregulated release, apoptosis (caspase-3 activation), secretory function, and presence of hypoxia markers (HIF-1a and VEGF expression) were assessed. Islets cultured in a matrix, had similar islet viability to controls (no matrix) but decreased levels of active caspase-3 and unregulated hormone release, but high level of hypoxia markers expression. Although the supplementation of fibrin with non-emulsified perfluorodecalin improves secretory response, there was no decrease in hypoxia markers expression. In contrast, emulsified perfluorodecalin added to the matrix improved islet function, islet viability and maintained level of hypoxia markers similar to control. Fibrin matrix supplemented with emulsified perfluorodecalin can provide a beneficial physical and chemical environment for improved pancreatic human islet function and viability in vitro.
AuthorsElisa Maillard, Maciej T Juszczak, Anne Clark, Stephen J Hughes, Derek R W Gray, Paul R V Johnson
JournalBiomaterials (Biomaterials) Vol. 32 Issue 35 Pg. 9282-9 (Dec 2011) ISSN: 1878-5905 [Electronic] Netherlands
PMID21899883 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011. Published by Elsevier Ltd.
Chemical References
  • Fluorocarbons
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Insulin
  • Vascular Endothelial Growth Factor A
  • perfluorodecalin
  • Fibrin
Topics
  • Cell Nucleus (drug effects, metabolism)
  • Extracellular Matrix (drug effects, metabolism)
  • Fibrin (pharmacology)
  • Fluorocarbons (pharmacology)
  • Humans
  • Hypoxia (pathology)
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Insulin (metabolism)
  • Islets of Langerhans (drug effects, metabolism, pathology, ultrastructure)
  • Organ Culture Techniques (methods)
  • Protein Transport (drug effects)
  • Tissue Survival (drug effects)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: